nach oben

Reactions Weekly

Erschienen in:

01.06.2018 | Case report

Methotrexate

Persistent elevations in ALT and intolerance due to nausea: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

A 28-year-old man developed nausea and persistent elevations in ALT during treatment with methotrexate [route, dosage and duration of treatment to reactions onsets not stated]. The man presented with inflammatory monoarthritis of the right knee. He initially received treatment with intermittent unspecified steroid injections and subsequently received treatment with methotrexate and sulfasalazine. However, methotrexate was discontinued as he developed persistent elevations in ALT and nausea [outcome of nausea not stated]. Additionally, sulfasalazine was ineffective. Eventually, his inflammatory monoarthritis of the right knee was successfully treated with etanercept. …

Suhail T, et al. The use of tumour necrosis factor inhibitors in disease modifying anti rheumatic drugresistant inflammatory monoarthritis of the knee. Rheumatology 57 (Suppl. 3): iii47 abstr. 012, 1 Apr 2018. Available from: URL: https://doi.org/10.1093/rheumatology/key075.236 [abstract] - United Kingdom

Titel: Methotrexate
Persistent elevations in ALT and intolerance due to nausea: case report
Publikationsdatum: 01.06.2018
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-018-48313-y

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Methotrexate

Persistent elevations in ALT and intolerance due to nausea: case report

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2018

Cabozantinib

Deferoxamine

Bortezomib

BCG

Irbesartan/valaciclovir

Voglibose